Quantum Biosciences presents Quantum Sentinel platform for early cancer treatment damage detection
Updated
Updated · The Hans India · Apr 30
Quantum Biosciences presents Quantum Sentinel platform for early cancer treatment damage detection
8 articles · Updated · The Hans India · Apr 30
The Bengaluru startup, incubated at CCAMP, showcased the technology at the Quantum India Bengaluru Summit and said it detects oxidative-stress injury in blood samples within hours of treatment exposure.
Using nanodiamond nitrogen-vacancy quantum biosensors, the platform generates an ex vivo radiosensitivity index intended to help oncologists personalise radiation doses, add protective drugs or switch regimens earlier.
The company says the approach could reduce long-term complications such as cardiotoxicity, neuropathy and kidney dysfunction, though broader clinical validation, large trials and regulatory clearances are still pending.
Will this quantum leap in detection create a new divide in cancer care between the rich and poor?
This tech predicts chemo damage in hours, but how many years until it reaches local cancer clinics?
Could this quantum test risk cancer treatment efficacy by prompting doctors to lower life-saving chemo doses?
Transforming Cancer Care: Quantum Biosciences’ Quantum Sentinel™ and the Radiation Toxicity Score for Personalized Treatment
Overview
Quantum Biosciences is advancing a quantum-enabled biosensor using nitrogen-vacancy centers in nanodiamonds, currently undergoing large-scale clinical trials supported by key industry partners and India's Nano Mission. This biosensor offers real-time, non-invasive monitoring with exceptional sensitivity, enabling the creation of a Radiation Toxicity Score (RTS) that helps personalize cancer treatment and predict toxic side effects early. The technology is expanding into detecting kidney toxicity and improving drug safety testing. Backed by India's National Quantum Mission, international collaborations, and a vibrant startup ecosystem, Quantum Biosciences is positioned to transform precision medicine by providing rapid, molecular-level insights that can improve patient outcomes and healthcare efficiency.